% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{vanEimeren:910745,
author = {van Eimeren, Thilo and Drzezga, Alexander},
title = {{F}rom molecules to system failure: translational frontiers
of multimodal imaging in neurodegenerative diseases},
journal = {European journal of nuclear medicine and molecular imaging},
volume = {46},
number = {13},
issn = {0340-6997},
address = {Heidelberg [u.a.]},
publisher = {Springer-Verl.},
reportid = {FZJ-2022-04115},
pages = {2816 - 2818},
year = {2019},
abstract = {Understanding the molecular and neural underpinnings of
neurodegenerative diseases is one of the greatest challenges
in today’s health-related research. To this end, the
translation of evidence from basic science (e.g., at the
molecular, cellular, or animal model level) to clinical
science is paramount, yet remains particularly hard to
achieve. Simultaneously, the plethora of evidence for the
clinical utility of molecular imaging has not yet lead to a
sufficiently available and standardized use in clinical
practice and there is a critical need of a
science-to-guidelines transition of these techniques. Both
tasks demand an iterative, multi-disciplinary, highly
collaborative approach. Following this formula, we started a
biannual symposium—called “Multimodal Imaging in
Neurodegeneration Cologne,” or short MINC—specifically
dedicated to bridge translational gaps in particularly
topical areas of research in neurodegenerative diseases. The
MINC symposium in October 2018 was focused on five topics:
the cause and effect of cerebral protein aggregation
pathologies (beta-amyloid, tau, and alpha-synuclein), the
various facets of neuroinflammation in neurodegenerative
diseases, non-dopaminergic transmitter dysfunction in
Parkinson’s disease, and the development of proteinaceous
agents for molecular PET imaging and for therapy. The great
success of this meeting was largely due to the gathering and
interaction of scientist from various disciplines who would
not usually meet at their respective science meetings. The 2
days of talks and discussions by experts in various fields
from basic to clinical science and imaging yielded many
intriguing insights. We have asked teams of participants of
the meeting to summarize the main insights from this
meeting. This resulted in three key chapters, which are
outlined below and discussed in greater depth in three
papers, which are published in this issue. We are extremely
grateful to the Deutsche Forschungsgemeinschaft (DFG) for
funding the MINC symposium (EI 892/5–1) and to the
European Journal of Nuclear Medicine and Molecular Imaging
for publishing these major outcomes of the MINC symposium as
three separate publications in this issue.},
cin = {INM-2},
ddc = {610},
cid = {I:(DE-Juel1)INM-2-20090406},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {31667539},
UT = {WOS:000502971900020},
doi = {10.1007/s00259-019-04562-7},
url = {https://juser.fz-juelich.de/record/910745},
}